Over the years, we have heard thousands of people fall ill and die due to the Ebola virus. Despite the medical advances and vaccines available, it has been difficult to contain and treat this virus up till recently. In fact, ever since this virus was discovered in 1976, there had been no treatment or vaccine for this disease till 2013! It was only after that that scientists began coming up with ways to handle the deadly strains of the virus. A vaccine was then developed that helped end the Ebola epidemic that swept through three West African countries between 2013 and 2016. However, the treatment only worked on one of the strains of Ebola, known as Zaire, and not on the other two strains – Sudan and Bundibugyo. Thus, those with these strains simply died with no effective treatment. This was then seen as a huge problem as during an epidemic, finding out which one of the three strains is causing the problem, and which individual is affected with which strain could be a time-consuming task that may lead the patients even more closer to death. Thus, there was a need to develop a single treatment that could work on all the three strains of Ebola.
The good news here is that working over the problem, scientists have now found such a solution! A drug cocktail named MBP134 is the perfect solution that can treat all the three strains of Ebola. It has helped monkeys infected with all the three Ebola strains to recover from the disease. And, the best part is that the treatment with this drug required only a single intravenous injection. Instead of this drug, if here different drugs were to be developed to treat the individual strains of Ebola, the process would not only become expensive, but may also result in time wastage to identify the strain before treating the patient; keeping him at risk till then. Thus, with the MBP134, people can be treated immediately, saving valuable time and innumerous number of lives, while also saving money.
Nevertheless, there is still further work that scientists are doing on this procedure. They are now looking to tweak the dose to the lowest possible amount, making it easier to distribute and reducing costs. This also makes it easier to conduct clinical trials in humans to ensure that the treatment is safe and effective. This seems to be a promise from scientists that countries affected by the Ebola virus can have a treatment ready to stop future Ebola outbreaks.
Help your country find such effective treatments for all kinds of ailments, and help your countrymen, and even those abroad, live a healthy life devoid of serious illnesses. If this seems to be a passion for you, the clinical research industry is waiting for you with open arms! Just get enrolled with the most appropriate clinical research diploma courses in Bangalore available at Avigna Clinical Research Institute, to get professional coaching and a legitimate certification that can help you get the best clinical research career ahead!
